The comparison of the level of stromal cells in 30 primary DCIS before recurrence and the control group of 11 DCIS without recurrence during the long-term follow-up showed a statistically significant difference for CD138 + cells, which were more prevalent in patients with invasive breast cancer relapse. Here, SDC1 is linked to ductal breast carcinoma in situ.